CLINICAL_TRIALS
trial_result
· 2017-06-05
Clinical Trial Update: Sirolimus Versus Anti-Vascular Endothelial Growth Factor (antiVEGF) for Wet AMD [Phase 2]
Summary
A Phase 2 trial comparing sirolimus to anti-VEGF therapy for wet age-related macular degeneration has completed, with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Maturi, Raj K., M.D., P.C. | Conditions: Age-Related Macular Degeneration | Phase 2 | Status: COMPLETED | Results posted: 2017-06-05